Cantor Fitzgerald Reiterates Overweight Rating on PTC Therapeutics (PTCT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 59.97 -4.49 (6.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.46 | 52 Week High | $35.40 | |||
| Open | $64.75 | 52 Week Low | $4.03 | |||
| Day High | $65.34 | P/E | 6.38 | |||
| Day Low | $59.64 | EPS | $9.40 | |||
| Volume | 2,357,636 | |||||
